Authors

• Yuki Etani (ORCID: https://orcid.org/0000-0001-5741-5969)
• Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
• Takaaki Noguchi (ORCID: https://orcid.org/0000-0001-9938-6780)
• Nobuko Horiuchi
• Kosuke Ebina (ORCID: https://orcid.org/0000-0002-2426-1024)
• Masanao Kyuuma
• Rumiko Matsumoto
• Shunsuke Okamoto (ORCID: https://orcid.org/0000-0002-9465-0375)
• Tsutomu Takeuchi (ORCID: https://orcid.org/0000-0003-1111-8218)

Institutions

• Taisho Pharmaceutical (Japan) (JP)
• University of Occupational and Environmental Health Japan (JP)
• Keio University (JP)
• Saitama Medical University (JP)
• The University of Osaka (JP)

Publication Details

Journal

RMD Open

Published

2025-10-01

DOI

https://doi.org/10.1136/rmdopen-2025-006218

Primary Topic

Rheumatoid Arthritis Research and Therapies

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Sanofi
• Ablynx